Nutriband (NASDAQ:NTRBW) Shares Down 0.9% – Here’s What Happened

Nutriband Inc. (NASDAQ:NTRBWGet Free Report) shares fell 0.9% during trading on Tuesday . The stock traded as low as $1.12 and last traded at $1.12. 100 shares were traded during trading, a decline of 96% from the average session volume of 2,391 shares. The stock had previously closed at $1.13.

Nutriband Price Performance

The company has a fifty day moving average price of $1.42 and a 200-day moving average price of $1.63.

Institutional Trading of Nutriband

A hedge fund recently bought a new stake in Nutriband stock. Empery Asset Management LP bought a new stake in shares of Nutriband Inc. (NASDAQ:NTRBWFree Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband comprises approximately 0.1% of Empery Asset Management LP’s portfolio, making the stock its 20th biggest holding.

About Nutriband

(Get Free Report)

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.

See Also

Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.